Status: current, Primitive. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1954271000168119 | Tazocin EF 2 g/250 mg (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1954281000168116 | Tazocin EF 2 g/250 mg | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazocin EF 2 g/250 mg | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | has TP | True | Tazocin EF 2 g/250 mg | Inferred relationship | Some | |
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | Is a | True | Tazocin EF 2 g/250 mg | Inferred relationship | Some | |
| Tazocin EF 2 g/250 mg powder for injection, 2.25 g vial | has TP | True | Tazocin EF 2 g/250 mg | Inferred relationship | Some |
Reference Sets
FHIR